The US government has announced collaborations with Johnson & Johnson and Moderna to simultaneously support clinical testing and the development of production infrastructure for COVID-19 vaccines, according to a statement from the US Department of Health and Human Services.
FDA Commissioner Fast-Tracking Potential Treatments for Coronavirus
FDA announced a new program geared at expediting the development of potentially safe and effective life-saving treatments. The program, known as the Coronavirus Treatment Acceleration Program (CTAP), is using every tool at the agency’s disposal to bring new therapies to sick patients as quickly as possible, while also supporting research to further evaluate whether these medical countermeasures are safe and effective for treating patients infected with this new virus.